Medicine and Dentistry
Paclitaxel
100%
Breast Cancer
50%
Biological Marker
33%
Patient
33%
Clustered Regularly Interspaced Short Palindromic Repeat
25%
Clinical Trial
25%
Protein
16%
Glioblastoma
16%
Ganglioglioma
16%
Glioma Cell
16%
Cells
16%
Protein Subunit
8%
Progression Free Survival
8%
Combination Therapy
8%
Phosphorylation
8%
Translocon
8%
Xenograft
8%
Cancer Cell
8%
Blood Brain Barrier
8%
Endoplasmic reticulum
8%
Pancreas Cancer
8%
Endoplasmic Reticulum Stress
8%
Chemotherapeutic Agent
8%
Drug
8%
Gene
8%
Obstetric Delivery
8%
Inpatient
8%
Regulatory Mechanism
8%
Survival
8%
INIS
cancer
50%
breasts
50%
patients
41%
biological markers
33%
gliomas
33%
proteins
25%
knock-out reactions
25%
screens
25%
correlations
16%
glioblastomas
16%
chemotherapy
16%
endoplasmic reticulum
16%
design
8%
levels
8%
humans
8%
drugs
8%
clinical trials
8%
therapy
8%
delivery
8%
genes
8%
hypothesis
8%
regulations
8%
validation
8%
blood-brain barrier
8%
phosphorylation
8%
pancreas
8%
sensors
8%
Pharmacology, Toxicology and Pharmaceutical Science
Paclitaxel
100%
Breast Cancer
50%
Biological Marker
33%
Chemotherapy
33%
Protein
16%
Glioblastoma
16%
Glioma
16%
Progression Free Survival
8%
Pancreas Cancer
8%
Taxane
8%
Drug
8%
Survival
8%
Biochemistry, Genetics and Molecular Biology
CRISPR
25%
Protein
16%
Protein Subunit
8%
Phosphorylation
8%
Nested Gene
8%
Cancer Cell
8%
Progression Free Survival
8%
Endoplasmic Reticulum Stress
8%
Blood Brain Barrier
8%
Translocon
8%
Regulatory Mechanism
8%
Survival
8%